Usage
:Viaminati is Tretinoin derivative and its structure approximate to all-trans-retinoic acid, the mechanism is similar to 13-Tretinoin and aromatic Tretinoin and the side-effect is less than all-trans-retinoic acid. Take it orally could regular and control the differentiation and growth of epithelial cell, inhibit thesecretion of sebum and process of cornification, also having the function of adjusting immunity function and anti-inflammation.
Viaminati is not a recognized pharmaceutical or chemical compound in global regulatory databases. No verified molecular formula, CAS number, or industrial synthesis process exists for this identifier. It appears to be a non-existent or misidentified product within the B2B chemical sector.
Due to lack of verified data, no safety protocols, storage conditions, or clinical restrictions can be defined. Users should verify product identity before procurement to avoid compliance risks.